المؤلفون: Kostenko, Emilia, Chantraine, Frédéric, Vandeweyer, Katleen, Schmid, Maximilian, Lefevre, Alex, Hertz, Deanna, Zelle, Laura, Bartha, Jose Luis, Di Renzo, Gian Carlo

المصدر: Fetal Diagnosis and Therapy, 45 (6), 413 - 423 (2019)

مصطلحات موضوعية: Cell-free DNA, Cost effectiveness, Down syndrome, Economic evaluation, Fetal diagnosis, Genetic testing, Maternal serum screening, Noninvasive prenatal diagnosis, Prenatal screening, Trisomy, Cost-Benefit Analysis, Decision Support Techniques, Female, Humans, Pregnancy, Uncertainty, Aneuploidy, Genetic Testing, Noninvasive Prenatal Testing, Pediatrics, Perinatology and Child Health, Embryology, Radiology, Nuclear Medicine and Imaging, Obstetrics and Gynecology, General Medicine, Human health sciences, Reproductive medicine (gynecology, andrology, obstetrics), Sciences de la santé humaine, Médecine de la reproduction (Gynécologie, andrologie, obstétrique)

Relation: https://www.karger.com/Article/Pdf/491750; urn:issn:1015-3837; urn:issn:1421-9964

URL الوصول: https://orbi.uliege.be/handle/2268/312138